FMS - Fresenius Medical Care AG & Co. KGaA
NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.86B |
| Enterprise value | 25.74B |
| Trailing P/E | 19.94 |
| Forward P/E | 13.50 |
| PEG ratio (5-yr expected) | 1.12 |
| Price/sales (ttm) | 0.61 |
| Price/book (mrq) | 0.87 |
| Enterprise value/revenue | 1.32 |
| Enterprise value/EBITDA | 7.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.90 |
| 52-week change 3 | -24.67% |
| S&P500 52-week change 3 | 2.72% |
| 52-week high 3 | 29.14 |
| 52-week low 3 | 12.79 |
| 50-day moving average 3 | 22.51 |
| 200-day moving average 3 | 18.16 |
Share statistics
| Avg vol (3-month) 3 | 750.36k |
| Avg vol (10-day) 3 | 409.48k |
| Shares outstanding 5 | 586.83M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 397.85M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 9.90% |
| Shares short (14 May 2023) 4 | 1.51M |
| Short ratio (14 May 2023) 4 | 2.46 |
| Short % of float (14 May 2023) 4 | N/A |
| Short % of shares outstanding (14 May 2023) 4 | 0.26% |
| Shares short (prior month 13 Apr 2023) 4 | 2.16M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 1.12 |
| Trailing annual dividend yield 3 | 5.11% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 64.17% |
| Dividend date 3 | 31 May 2023 |
| Ex-dividend date 4 | 12 May 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 03 Dec 2012 |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 3.08% |
| Operating margin (ttm) | 7.62% |
Management effectiveness
| Return on assets (ttm) | 2.65% |
| Return on equity (ttm) | 5.49% |
Income statement
| Revenue (ttm) | 19.55B |
| Revenue per share (ttm) | 33.33 |
| Quarterly revenue growth (yoy) | 3.40% |
| Gross profit (ttm) | 5.31B |
| EBITDA | 2.4B |
| Net income avi to common (ttm) | 602.41M |
| Diluted EPS (ttm) | 1.12 |
| Quarterly earnings growth (yoy) | -45.10% |
Balance sheet
| Total cash (mrq) | 1.22B |
| Total cash per share (mrq) | 2.09 |
| Total debt (mrq) | 13.27B |
| Total debt/equity (mrq) | 87.12 |
| Current ratio (mrq) | 1.32 |
| Book value per share (mrq) | 23.56 |
Cash flow statement
| Operating cash flow (ttm) | 2.15B |
| Levered free cash flow (ttm) | 1.08B |
© 2023 Yahoo. All rights reserved.